Nus Scholarbankmetadata only
Comparison of weekly and daily recall of pain as an endpoint in a randomized phase 3 trial of cabozantinib for metastatic castration-resistant prostate cancer
mental recall, randomized phase 3 drug trial, cancer pain, patient-reported outcome
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 645107
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.